Chenqi Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chenqi Xu has a total of 579 co-authors. Here are the top co-authors by number of shared publications:
- Haoyu Sun
Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China
20 shared publications - Hui Peng
State Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of Institute of Health and Medicine, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China
20 shared publications - Rui Sun
State Key Laboratory of Immune Response and Immunotherapy, the Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
20 shared publications - Xianwei Wang
State Key Laboratory of Immune Response and Immunotherapy, the Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
20 shared publications - Xiaodong Zheng
State Key Laboratory of Immune Response and Immunotherapy, Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China
20 shared publications - Yongjing Shi
Key Laboratory of Immune Response and Immunotherapy, The Institute of Immunology, Biomedical Sciences and Health Laboratory of Anhui Province, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. 1
20 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Research Square
Phosphatidylethanolamine lipids secreted by CD8⁺ T cells mediate cytotoxic immunity
Current understanding of T-cell immunity largely focuses on protein factors responsible for immune surveillance and regulation, with limited exploration of the roles played by other molecular types. While proteins such as perforin and granzymes are well-established mediators of CD8⁺ T cell cytotoxicity 1-5 , our study uncovers the cone-shaped phosphatidylethanolamine (PE) lipids as a new class of effector molecules with broad cytotoxic functions against tumor and infected cells. Upon activation, CD8⁺ T cells upregulated the de novo biosynthesis pathway to produce substantial amounts of PE lipids carrying polyunsaturated or monounsaturated fatty acid sidechains. The newly synthesized PE lipids were packaged into vesicular compartments distinct from Lamp1⁺ granules, rapidly polarized to immunological synapses, and secreted through the membrane fusion protein Munc13-4, generating PE⁺ extracellular vesicles enriched in synaptic lipids and proteins. CD8-derived PE lipids were efficiently taken up by target cells and transported to the endoplasmic reticulum via Esyt1, where excessive PE loading induced ER stress and triggered Chop-dependent cell death within a few hours. The PE pathway functioned independently of conventional cytotoxic mechanisms and remained effective even when those pathways were absent. Manipulation of the PE-Esyt1-ER stress axis markedly altered T cell cytotoxicity, and ethanolamine pretreatment of T cells enhanced the efficacy of adoptive cell therapy. These findings introduce a new lipid-based mechanism of cytotoxic immunity and underscore the importance of non-protein molecules as immune effectors.
- 3 November 2026
- Published by Springer Nature in Research Square
Open AccessPhosphatidylethanolamine lipids secreted by CD8⁺ T cells mediate cytotoxic immunity
Current understanding of T-cell immunity largely focuses on protein factors responsible for immune surveillance and regulation, with limited exploration of the roles played by other molecular types. While proteins such as perforin and granzymes are well-established mediators of CD8⁺ T cell cytotoxicity 1-5 , our study uncovers the cone-shaped phosphatidylethanolamine (PE) lipids as a new class of effector molecules with broad cytotoxic functions against tumor and infected cells. Upon activation, CD8⁺ T cells upregulated the de novo biosynthesis pathway to produce substantial amounts of PE lipids carrying polyunsaturated or monounsaturated fatty acid sidechains. The newly synthesized PE lipids were packaged into vesicular compartments distinct from Lamp1⁺ granules, rapidly polarized to immunological synapses, and secreted through the membrane fusion protein Munc13-4, generating PE⁺ extracellular vesicles enriched in synaptic lipids and proteins. CD8-derived PE lipids were efficiently taken up by target cells and transported to the endoplasmic reticulum via Esyt1, where excessive PE loading induced ER stress and triggered Chop-dependent cell death within a few hours. The PE pathway functioned independently of conventional cytotoxic mechanisms and remained effective even when those pathways were absent. Manipulation of the PE-Esyt1-ER stress axis markedly altered T cell cytotoxicity, and ethanolamine pretreatment of T cells enhanced the efficacy of adoptive cell therapy. These findings introduce a new lipid-based mechanism of cytotoxic immunity and underscore the importance of non-protein molecules as immune effectors.
- 14 September 2026
- Published by Springer Nature in Cell Research
- Vol. 36 (10) , 830-832
Author Correction: Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness
- 14 September 2026
- Published by Springer Nature in Cell Research
- Vol. 36 (10) , 830-832
Author Correction: Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness
- Open Access
Spatial cholesterol homeostasis gatekeeps T-cell development and activation by orchestrating signaling and fitness
Cholesterol is essential for T-cell immunity, and its spatial distribution is tightly regulated. Although cholesterol is synthesized in the endoplasmic reticulum (ER), it is predominantly transported to the plasma membrane (PM); however, the machinery mediating this anterograde transport in T cells remains unknown. Here, through a functional genetic screen, we identify oxysterol-binding protein (OSBP) as the principal mediator of ER-to-PM cholesterol transport in T cells. OSBP deficiency depletes accessible PM cholesterol while causing cholesterol accumulation in the ER, resulting in impaired T-cell receptor (TCR) signaling and disruption of ER homeostasis. Using stage-specific conditional knockout mice, we demonstrate that OSBP is required at multiple developmental checkpoints in the thymus, including β-selection, positive selection, and post-selection maturation. Loss of OSBP during early thymocyte development causes a near-complete block in T-cell development, resulting in a profound absence of mature peripheral T cells. In mature T cells, activation markedly increases dependence on OSBP-mediated cholesterol transport, with its inhibition causing ER perturbation and extensive cell death. Finally, we show that disease-associated oxysterols disrupt OSBP-mediated cholesterol transport, leading to T-cell dysfunction and providing a mechanistic explanation for impaired T-cell immunity in pathological settings. Together, our findings identify OSBP as a central regulator of intracellular cholesterol transport that couples membrane cholesterol homeostasis to TCR signaling and ER integrity. These results establish the spatial distribution of cholesterol, rather than its abundance alone, as a fundamental metabolic determinant of thymocyte development and peripheral T-cell function.
Open AccessSpatial cholesterol homeostasis gatekeeps T-cell development and activation by orchestrating signaling and fitness
Cholesterol is essential for T-cell immunity, and its spatial distribution is tightly regulated. Although cholesterol is synthesized in the endoplasmic reticulum (ER), it is predominantly transported to the plasma membrane (PM); however, the machinery mediating this anterograde transport in T cells remains unknown. Here, through a functional genetic screen, we identify oxysterol-binding protein (OSBP) as the principal mediator of ER-to-PM cholesterol transport in T cells. OSBP deficiency depletes accessible PM cholesterol while causing cholesterol accumulation in the ER, resulting in impaired T-cell receptor (TCR) signaling and disruption of ER homeostasis. Using stage-specific conditional knockout mice, we demonstrate that OSBP is required at multiple developmental checkpoints in the thymus, including β-selection, positive selection, and post-selection maturation. Loss of OSBP during early thymocyte development causes a near-complete block in T-cell development, resulting in a profound absence of mature peripheral T cells. In mature T cells, activation markedly increases dependence on OSBP-mediated cholesterol transport, with its inhibition causing ER perturbation and extensive cell death. Finally, we show that disease-associated oxysterols disrupt OSBP-mediated cholesterol transport, leading to T-cell dysfunction and providing a mechanistic explanation for impaired T-cell immunity in pathological settings. Together, our findings identify OSBP as a central regulator of intracellular cholesterol transport that couples membrane cholesterol homeostasis to TCR signaling and ER integrity. These results establish the spatial distribution of cholesterol, rather than its abundance alone, as a fundamental metabolic determinant of thymocyte development and peripheral T-cell function.
- 10 August 2026
- Published by Elsevier in Cancer Cell
- Vol. 44 (9) , 1727-1729
Latent tumor killers awakened
- 10 August 2026
- Published by Elsevier in Cancer Cell
- Vol. 44 (9) , 1727-1729
Latent tumor killers awakened
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S1. Down regulation of FBXO38 in IT NK cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S1. Down regulation of FBXO38 in IT NK cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S3. FBXO38 knockout does not affect spleen NK cell development and effector function
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S3. FBXO38 knockout does not affect spleen NK cell development and effector function
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S2. Tumor grown faster in cKO mice than Ncr1Cre/+ mice
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S2. Tumor grown faster in cKO mice than Ncr1Cre/+ mice
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S7. FBXO38 promotes human NK-92 cell proliferation in vitro
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S7. FBXO38 promotes human NK-92 cell proliferation in vitro
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S6. FBXO38 deficiency increases the expression of suppressors of cell cycle program in TINK cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling
Supplementary Figure S6. FBXO38 deficiency increases the expression of suppressors of cell cycle program in TINK cells